| N | Whole group, n = 177 | CSA group, n = 105 (59.3%) | OSA group, n = 36 (20.3%) | TECSA group n = 36 (20.3%) | P |
---|---|---|---|---|---|---|
Anthropometric data | ||||||
Age (years) | 177 | 71 [65–77] | 71.00 [65.00–76.00] | 69.50 [65.00–77.00] | 74.50 [64.00–83.50] | 0.447 |
Gender, n (%) | 177 | Â | Â | Â | Â | 0.378 |
 Male |  | 155 (87.57%) | 93 (88.57%) | 33 (91.67%) | 29 (80.56%) |  |
 Female |  | 22 (12.43%) | 12 (11.43%) | 3 (8.33%) | 7 (19.44%) |  |
BMI (kg/m2) | 175 | 29.90 [26.60–34.00] | 29.80 [26.55–33.60] | 29.10 [26.70–35.00] | 31.55 [26.70–36.05] | 0.530 |
Initial sleep data | ||||||
 Initial exam | ||||||
  PG |  | 101 (57.06%) | 55 (52.38%) | 22 (61.11%) | 24 (66.67%) | 0.281 |
  PSG |  | 76 (42.92%) | 50 (47.62%) | 14 (38.89%) | 12 (33.33%) |  |
 Initial AHI (n/h) | 177 | 50.00 [38.30–62.30] | 50.00 [39.00–67.00] | 46.80 [34.75–58.50] | 47.05 [39.00–65.15] | 0.671 |
 Initial OAI (n/h) | 154 | 7.70 [2.00–18.30] | 4.00ab [0.90–8.70] | 16.45b [9.80–21.80] | 18.45a [7.15–28.15] | <.001 |
 Initial CAI (n/h) | 154 | 10.75 [3.60–23.60] | 17.00ab [9.00–33.80] | 7.50bc [2.50–9.80] | 3.50ac[0.65–7.70] | <.001 |
 Initial MAI (n/h) | 153 | 1.70[0.00–5.00] | 1.50 [0.00–4.65] | 4.00 [0.00–9.70] | 0.75 [0.00–7.00] | 0.279 |
 Initial HI (n/h) | 161 | 16.00 [8.70–24.90] | 16.75 [8.70–24.30] | 12.00 [8.35–23.50] | 17.00 [11.00–27.00] | 0.641 |
 Initial ESS score | 136 | 10.00 [6.00–13.50] | 10.00 [6.00–13.00] | 9.00 [4.00–14.00] | 12.00 [6.50–13.50] | 0.598 |
 CPAP trial before ASV initiation, n (%) | 166 | 91 (54.82%) | 36ab (37.11%) | 19bc (57.58%) | 36ac (100%) | < 0.001 |
Final sleep data | ||||||
 Final AHIflow | 177 | 1.90 [0.70–3.80] | 1.80 [0.70–3.30] | 1.95 [0.85–5.35] | 2.25 [0.50–4.80] | 0.448 |
 Final ESS score | 174 | 6.00 [3.0–9.0] | 5.00 [3.0–9.0] | 5.00 [2.0–10.0] | 6.00 [3.0–10.0] | 0.731 |
ASV-adherence | ||||||
 Mean adherence > 4 h/day, n (%) | 177 | 154 (87.01%) | 99 (94.29%)a | 30 (83.33%) | 25 (69.44%)a | < 0.001 |